drugset / Trial / NCT00006219
Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma
RandomizedDouble-blindPrevention
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. Dehydroepiandrosterone and clarithromycin may be effective in preventing multiple myeloma. PURPOSE: Randomized phase II trial to compare the effectiveness of dehydroepiandrosterone with that of clarithromycin in treating patients who may be at a high risk of developing multiple myeloma.
Timeline
- Start
- 2000-08
- Primary completion
- 2006-12
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clarithromycin | Small molecule | — | Oral |
| Subject | Dehydroepiandrosterone | Other / unclassified | — | Oral |